XML 31 R12.htm IDEA: XBRL DOCUMENT v3.25.4
Net Loss Per Share
 12 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Net Loss Per Share Net Loss Per Share
The following table sets forth the computation of basic and diluted net loss per share for the years ended December 31, 2025 and 2024 (in thousands, except number of shares and per share amounts):
Year Ended December 31,
Numerator:20252024
Net loss$(66,458)$(61,183)
Net loss attributable to noncontrolling interest30 109 
Net loss attributable to Barinthus Biotherapeutics plc shareholders$(66,428)$(61,074)
Denominator:
Weighted-average ordinary shares outstanding, basic40,527,21839,348,240
Weighted-average ordinary shares outstanding, diluted40,527,21839,348,240
Net loss per share attributable to ordinary shareholders, basic$(1.64)$(1.55)
Net loss per share attributable to ordinary shareholders, diluted$(1.64)$(1.55)
Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share, as the inclusion of all potential ordinary share equivalents outstanding would have been anti-dilutive. For the year ended December 31, 2025, 5,976,157 (December 31, 2024: 7,285,275) potential ordinary shares issuable for stock options were excluded from the computation of diluted weighted-average shares outstanding because including them would have had an anti-dilutive effect.